Status Epilepticus & the EcLiPSE Trial

Status epilepticus is the most common paediatric neurological emergency in the UK and the second most common reason for unplanned PICU admission in the UK. Dr Colin Gilhooley defines status epilepticus before discussing the EcLiPSE trial: Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial This was a UK wide trial across 30 Emergency Departments (including our own in Nottingham) comparing Phenytoin as the standard 2nd line treatment to Levetiracetam as an alternative with a smaller side effect profile. The result was (spoilers): NO SIGNIFICANT DIFFERENCE. Colin take us through the potential consequences of this, how this might change practice as well as what it was like to be involved in the trial and what deferred consent might mean in the future. You can find the blog for this episode at As ever you can

You can listen to Status Epilepticus & the EcLiPSE Trial online on Radio and Podcast. Open the player on this page to stream the available audio.

Status Epilepticus & the EcLiPSE Trial is an episode from Take Aurally by Take Aurally.

This episode is 00:17:59 long.

This episode was published on Jul 26, 2019.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Take Aurally when more episodes are available from the podcast feed.